GOSS — GOSSAMER BIO INC

Ownership history in Focus Partners Wealth  ·  3 quarters on record

This page tracks every 13F SEC filing in which Focus Partners Wealth reported a position in GOSSAMER BIO INC (GOSS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.0%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,325,198 +175,198 +15.2% 0.01% $3.5M $2.63
2025 Q2 ADDED 1,150,000 +450,000 +64.3% 0.00% $1.4M $1.23
2025 Q1 INITIATED 700,000 — — 0.00% $770K $1.10
% of Fund (quarterly)    GOSS price (monthly, adj. close)

Other funds also holding GOSS

As of 2025 Q4 — sorted by position size

Octagon Capital Advisors LP 3Y 5.24% ARCH Venture Management, LLC 3Y 7Y 3.83% NEA Management Company, LLC 3Y 7Y 2.86% MB Generational Wealth, LLC 2.63% Samsara BioCapital, LLC 3Y 7Y 2.31% Palo Alto Investors LP 3Y 7Y 1.93% Monashee Investment Management LLC 3Y 7Y 1.75% Opaleye Management Inc. 3Y 7Y 1.11% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.92% 683 Capital Management, LLC 3Y 7Y 0.7%
← Back to Focus Partners Wealth Holdings